IHS Chemical Week

EnviroTech :: Biotech

Lonza Signs Manufacturing Deal with French Biopharma Firm

11:47 PM MDT | July 15, 2009 | Deepti Ramesh

Lonza says it has signed an agreement with biopharmaceutical company LFB (Les Ulis, France) to manufacture a monoclonal anti-RhD antibody developed by LFB. The process developed by LFB will be transferred to Lonza which will provide manufacturing services for supporting the phase III clinical program, under the deal. Lonza will also support LFB in its regulatory submissions by providing appropriate documentation. Financial details of the agreement were not disclosed. LFB is the leading manufacturer of plasma-derived medicinal products in France and sixth...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa